MedPath

Mechanisms by which fruit and vegetables influence postmenopausal bone health: a randomised controlled trial in a well-characterised populatio

Completed
Conditions
ow bone mass/risk of osteoporosis
Musculoskeletal Diseases
Osteoporosis
Registration Number
ISRCTN86186352
Lead Sponsor
Food Standards Agency (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
260
Inclusion Criteria

Women aged 55 years to 65 years who had taken part in a longitudinal study (Aberdeen Prospective Osteoporosis Screening Study). Includes:
1. Otherwise healthy women taking other types of diuretics (not potassium sparing diuretics) or hypertension tablets
2. Women on thyroxine treatment provided their thyroid function is stable (as assessed by free Thyroxine [T4] and Thyroid Stimulating Hormone [TSH] levels) and their dose had not changed in the year prior to study entry

Exclusion Criteria

1. Suffering from severe disease
2. Malabsorption
3. Having difficulties swallowing tablets/capsules
4. Taking oral corticosteroids
5. On or past bisphosphonate treatment (more than a few weeks)
6. Taking Hormone Replacement Therapy (HRT) in the last six months
7. Less than five years past the menopause
8. Currently taking potassium-sparing diuretics
9. Osteoporosis diagnosed from Dual Energy X-ray Absorptiometry (DEXA) scan at baseline visit

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath